| |
|
|
 
Dawson James Securities has
analysts covering multiple companies in the biotech, healthcare,
technology and clean tech space. Our analysts have appeared on national TV,
financial media, scientific publications and mass media.
They are recognized as authorities on oncology drugs, stem cells, gene
therapy, drug delivery, cardiovascular, orthopedic therapeutics and
devices. Their expertise is often sought by CEOs and BODs.
Our research helps to
provide our clients the confidence to make rational investment decisions
in the complex fast-moving healthcare, biotechnology, technology and
clean tech industries.
|
|
